Assessment of tau phosphorylation and β-amyloid pathology in human drug-resistant epilepsy.

These findings strongly support the existence of hyperphosphorylated tau protein and Aβ deposits in patients with human refractory epilepsy. However, their relation to cognitive decline is still unclear and requires further investigation.